Loading

Panel discussion: What is the data telling us about the clinical pathway to safe and efficacious in vivo gene therapy products?

19 Jan 2027
Theatre 3
Innovation in Gene Delivery
Speakers
Prof Mark Kay, Dennis Farrey Family Professor, Departments of Pediatrics and Genetics; Head, Division of Human Gene Therapy - Stanford University
Dr Kate Excoffon, CEO and Co-Founder - Gene Tx Optimized, LLC
Dr Mercedes Segura Gally, VP Process Development - Editas Medicine

Topic

Clinical Development & Regulatory Strategy,Gene Therapy,Delivery or Vectors,Preclinical & Translational Development

Persona

Academic & Clinical Researchers,Biotech,Clinicians,Pharma,Service Providers (CDMOs CROs & Suppliers),Tools tech & equipment providers